Advil Allergy Sinus

Catarrh, Migraine, Coughing + 55 more
Treatment
6 FDA approvals
20 Active Studies for Advil Allergy Sinus

What is Advil Allergy Sinus

ChlorpheniramineThe Generic name of this drug
Treatment SummaryPseudoephedrine is a drug related to ephedrine, which is found in the ephedra plant used in traditional Eastern medicine. It has a weaker effect on the sympathetic nervous system than ephedrine and was first studied in the West in 1889. In 1927, it was discovered that pseudoephedrine had a decongestant effect in dogs.
Rynatussis the brand name
image of different drug pills on a surface
Advil Allergy Sinus Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Rynatuss
Chlorpheniramine
1960
47

Approved as Treatment by the FDA

Chlorpheniramine, also known as Rynatuss, is approved by the FDA for 6 uses including Cold and Acute Bronchitis .
Cold
Used to treat Cold in combination with Hydrocodone
Acute Bronchitis
Used to treat Cough in combination with Hydrocodone
Allergic Rhinitis (AR)
Allergy to Tree Pollen
upper respiratory symptoms
Used to treat upper respiratory symptoms in combination with Hydrocodone
Hypersensitivity
Used to treat Allergic Reaction in combination with Hydrocodone

Effectiveness

How Advil Allergy Sinus Affects PatientsPseudoephedrine helps to clear nasal congestion by narrowing the blood vessels in the nose. Its effects will usually only last a short time, unless it is taken as an extended release product. People should be aware of the possibility of feeling more alert or having trouble sleeping when taking this drug.
How Advil Allergy Sinus works in the bodyPseudoephedrine acts on alpha and beta adrenergic receptors, helping to reduce congestion and treat priapism. It also inhibits the transporters of norepinephrine, dopamine, and serotonin. These effects cause a rise in blood pressure, heart rate, and muscle activity in the right atrium. Additionally, pseudoephedrine is an agonist of the anococcygeal muscle and an inhibitor of certain proteins, including NF-kappa-B, NFAT, and AP-1.

When to interrupt dosage

The dosage of Advil Allergy Sinus is contingent upon the diagnosed condition, including Upper Respiratory Tract Infection, Airway secretion clearance therapy and Coughing. The dose likewise shifts as indicated by the method of delivery (e.g. Tablet, extended release or Oral) listed in the table below.
Condition
Dosage
Administration
Catarrh
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Migraine
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Coughing
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Allergy to vaccine
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
upper respiratory symptoms
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Sneezing
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Asthma
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Hives
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Acute Bronchitis
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Angioedema
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Acute Bronchitis
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Cold
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Migraine
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Sinusitis
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Pink Eye
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Rhinorrhea
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Conjunctivitis
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Productive cough
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
Seasonal Allergic Conjunctivitis
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets
House Dust Mite Allergy
, 1.0 mg/mL, 0.2 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 2.0 mg/mL, 2.0 mL/mL, 4.0 mg/mL, 12.0 mg, 0.002 mg/mg, 0.0004 mg/mg, 0.75 mg/mL, 8.0 mg/mL, 9.0 mg, 1.995 mg/mL, 0.999 mg/mL, 1.001 mg/mL, 0.01 mg/mg, 0.03 mg/mg, 0.00025 mg/mg, 0.25 mg/mL, 0.6 mg/mL, 1.05 mg, 1.0 mg, 0.5 mg, 0.0125 mg/mg, 1.25 mg/mL, 0.667 mg, 4.5 mg/mL, 1.25 mg, 2.0 mg/mg, 0.002 mg, 24.0 mg, 0.4 mg/mL, 3.0 mg, 2.8 mg/mL, 3.5 mg, 0.001 mg/mg, 6.25 mg, 5.0 mg/mL, 0.1 mg/mL, 0.8 mg/mL, 5.0 mg, 4.5 mg, 10.0 mg/mL, 0.00087 mg/mg, 2.5 mg/mL, 0.004 mg/mg, 0.5 mg/mL, 1.5 mg/mL
, Liquid - Oral, Oral, Liquid, Tablet, Solution, Solution - Oral, Tablet - Oral, Syrup - Oral, Tablet, coated, Syrup, Tablet, coated - Oral, Suspension - Oral, Suspension, Capsule, extended release, Capsule, extended release - Oral, Tablet, film coated, Tablet, film coated - Oral, Powder, for solution, Capsule, liquid filled, Tablet, effervescent - Oral, Granule, effervescent - Oral, Granule, effervescent, Tablet, effervescent, Capsule, liquid filled - Oral, Powder, for solution - Oral, Capsule, Capsule - Oral, Tablet, extended release, Tablet, extended release - Oral, Granule, Granule - Oral, Suspension, extended release - Oral, Suspension, extended release, Kit, Tablet, film coated, extended release - Oral, Tablet, film coated, extended release, Capsule, gelatin coated, Capsule, gelatin coated - Oral, Powder, Powder - Oral, Tablet, sugar coated, Tablet, sugar coated - Oral, Tablet, chewable - Oral, Tablet, chewable, Tablet, multilayer, Tablet, multilayer - Oral, Lozenge - Oral, Lozenge, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Granule, for solution, Granule, for solution - Oral, Liquid; Tablet - Oral; Parenteral, Oral; Parenteral, Liquid; Tablet, Intramuscular; Intravenous; Subcutaneous, Intramuscular; Oral; Subcutaneous, Liquid; Tablet - Intramuscular; Oral; Subcutaneous, Liquid - Intramuscular; Intravenous; Subcutaneous, Kit; Tablet; Tablet, extended release - Oral, Kit; Tablet - Oral, Kit; Tablet, Kit; Powder, for solution - Oral, Kit; Powder - Oral, Topical, Liquid - Topical, Kit; Tablet; Tablet, extended release, Kit; Powder, Kit - Oral, Solution / drops, Kit; Powder, for solution, Solution / drops - Oral, Nasal, Solution / drops - Nasal, Tablet, multilayer, extended release, Tablet, multilayer, extended release - Oral, Capsule, coated pellets - Oral, Capsule, coated pellets

Warnings

Advil Allergy Sinus has five counter-indications and should not be taken for the conditions listed in the following table.There are 20 known major drug interactions with Advil Allergy Sinus.
Common Advil Allergy Sinus Drug Interactions
Drug Name
Risk Level
Description
Amoxapine
Major
The metabolism of Amoxapine can be decreased when combined with Chlorpheniramine.
Anagrelide
Major
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Anagrelide.
Arsenic trioxide
Major
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Arsenic trioxide.
Artemether
Major
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Artemether.
Asenapine
Major
The risk or severity of QTc prolongation can be increased when Chlorpheniramine is combined with Asenapine.
Advil Allergy Sinus Toxicity & Overdose RiskThe toxic dose of pseudoephedrine in rats is 2206mg/kg and in mice is 726mg/kg. An overdose of pseudoephedrine can cause symptoms such as dizziness, headaches, nausea, vomiting, sweating, rapid heartbeat, chest pain, difficulty urinating, muscle weakness, anxiety, restlessness, insomnia, hallucinations, abnormal heart rhythms, shock, seizures, unconsciousness, and difficulty breathing. Treatment for an overdose includes providing supportive care and removing any unabsorbed drug from the body.
image of a doctor in a lab doing drug, clinical research

Advil Allergy Sinus Novel Uses: Which Conditions Have a Clinical Trial Featuring Advil Allergy Sinus?

Currently, there are 270 active studies exploring the potential of Advil Allergy Sinus to alleviate Allergies, Migraine Headaches and Ocular Symptoms.
Condition
Clinical Trials
Trial Phases
Migraine
51 Actively Recruiting
Phase 4, Not Applicable, Phase 1, Phase 3, Phase 2, Early Phase 1
Asthma
92 Actively Recruiting
Phase 1, Phase 4, Early Phase 1, Phase 2, Not Applicable, Phase 3
Transfusion Reaction
0 Actively Recruiting
Pink Eye
0 Actively Recruiting
Nasal Congestion
0 Actively Recruiting
Hypersensitivity
1 Actively Recruiting
Phase 4
Headache
0 Actively Recruiting
ocular hyperemia
0 Actively Recruiting
Influenza
0 Actively Recruiting
Conjunctivitis
0 Actively Recruiting
Coughing
0 Actively Recruiting
Airway secretion clearance therapy
0 Actively Recruiting
Nose
0 Actively Recruiting
Allergy to vaccine
0 Actively Recruiting
Angioedema
0 Actively Recruiting
Rhinorrhea
0 Actively Recruiting
Seasonal Allergic Conjunctivitis
0 Actively Recruiting
Cold
0 Actively Recruiting
Lacrimal Apparatus Diseases
0 Actively Recruiting
Coughing
0 Actively Recruiting

Advil Allergy Sinus Reviews: What are patients saying about Advil Allergy Sinus?

5Patient Review
8/30/2010
Advil Allergy Sinus for Stuffy Nose
I find this medication much easier to take than prescriptions. Prescriptions always made me feel out of it and foggyheaded, but I don't get that with this at all.
4Patient Review
9/18/2007
Advil Allergy Sinus for Sinus Headache
This helped take the edge off my headache without making me drowsy, which is exactly what I need.
4Patient Review
7/11/2011
Advil Allergy Sinus for Allergic Conjunctivitis
This is a test.
3Patient Review
1/16/2010
Advil Allergy Sinus for Stuffy Nose
While this medication is effective, I found that it interfered with my sleep when taken at night. My heart rate would slow down to the point where it woke me up.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about advil allergy sinus

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does Advil help sinus allergies?

"This medication is designed to treat tough allergy symptoms, including nasal congestion. Other allergy medications typically don't provide this same level of relief. Advil includes a combination of ibuprofen, an antihistamine, and a decongestant, which work together to relieve upper respiratory symptoms caused by allergies."

Answered by AI

What does Advil allergy and sinus do?

"Phenylephrine (a decongestant) works by constricting the blood vessels in your nose.

Advil Allergy Sinus contains a combination of three medications - chlorpheniramine (an antihistamine), ibuprofen (an NSAID), and phenylephrine (a decongestant). Chlorpheniramine and ibuprofen work by blocking certain chemicals in your body that cause inflammation (swelling). Phenylephrine works by constricting the blood vessels in your nose."

Answered by AI

Does Advil Allergy Sinus make you drowsy?

"This medication comes in a caplet form and is usually taken every 4 to 6 hours with food. Some common side effects of Advil Allergy Sinus include stomach upset, fast heart rate, and shakiness. Another possible side effect is drowsiness."

Answered by AI

How long does Advil allergy and congestion last?

"The combination of phenylephrine HCl 10mg and chlorpheniramine maleate 4 mg helps to control runny nose, sneezing, sinus pressure, nasal congestion and swelling, and itchy, watery eyes. Just one of these tablets helps control your tough allergy and sinus symptoms for four hours."

Answered by AI

Clinical Trials for Advil Allergy Sinus

Image of Johns Hopkins Medicine in Baltimore, United States.

Embolization for Migraine

18 - 80
All Sexes
Baltimore, MD
This study is to test the safety and feasibility of a procedure called embolization of the middle meningeal arteries (MMA), using a product called Onyx. Embolization creates a plug in the arteries. MMA embolization with Onyx is not approved for use in patients with migraines, but is currently used in patients with subdural hematomas. The FDA is allowing the use of Onyx in this study. It is thought that by using Onyx to block the middle meningeal arteries, the amount of migraine-causing substances which are released into the brain's bloodstream will be reduced. The company that manufactures Onyx, Medtronic, is providing the supplies for this study. Participants will be in the study for about 8 months after enrolling, including 6 months of follow up after the procedure. The participants will be asked to complete a daily headache diary and continue the participant's regular migraine medications. Participants will also have several clinic visits and be asked to provide blood samples for research.
Waitlist Available
Has No Placebo
Johns Hopkins MedicineRisheng Xu, MD, PhDMedtronic
Have you considered Advil Allergy Sinus clinical trials? We made a collection of clinical trials featuring Advil Allergy Sinus, we think they might fit your search criteria.Go to Trials
Image of Vanderbilt University Medical Center in Nashville, United States.

High vs. Standard Dose Influenza Vaccines for Flu

18+
All Sexes
Nashville, TN
This will be a follow-up study to the "Comparison of High Dose vs. Standard Dose Influenza Vaccine in Lung Allograft Recipient" study (DMID Protocol Number 22-0014) at Vanderbilt University Medical Center. Lung transplantation is a life-saving therapy for patients with advanced lung disease, and is also associated with an improvement in quality of life. However, due to the need for life-long immunosuppression to prevent acute cellular rejection and chronic lung allograft dysfunction ("chronic rejection"), lung transplant recipients are at risk for developing major infections. In fact, one-year survival is 85%, with infection being the leading cause of death within the first year post-transplant. We will conduct a follow-up phase II, randomized, double-blind trial to assess the impact of subsequent administration of two doses of HD-IIV compared to two doses of SD-IIV among lung recipients during the early post-transplant period. Demonstration of improved immunogenicity from two doses of HD-IIV over consecutive influenza seasons would provide potential broad benefit in reducing influenza disease and its associated complications in lung transplant recipients. Moreover, studying vaccine immunogenicity and safety in the same participants over consecutive years can provide insight into the influence of immunosuppression levels and allograft aging on vaccine-mediated immune modulation. This proposed study design will contribute significantly to influenza vaccination guidance and policy for the highly vulnerable lung transplant population. This proposed study is designed to address several key knowledge gaps in vaccine-mediated protection of lung transplant recipients against influenza: * Is there increased immunogenicity with administration of one or two doses of HD-IIV or SD-IIV in the subsequent season compared to two doses of HD-IIV or SD-IIV in the first season? * What is the durability of the humoral and cellular immune response between influenza seasons and does two doses of HD-IIV or SD-IIV sustain higher HAI titers compared to two doses of HD-IIV or SD-IIV in the first season? * What is the impact of maintenance immunosuppression levels on influenza vaccine immunogenicity within the same participant? * Will the optimal immunogenic vaccination strategy be associated with an acceptable long-term safety profile over successive influenza seasons, including injection-site and systemic reactions, allosensitization, and organ rejection?
Phase 2
Recruiting
Vanderbilt University Medical CenterNatahsa Halasa, MD, MPH
Image of Altasciences Inc - Kansas City in Overland Park, United States.

VNT-101 for Safety and Tolerability Study

18 - 59
All Sexes
Overland Park, KS
A randomized, double-blind, placebo-controlled Phase 1 study conducted at a single center with approximately 78 healthy adults aged 18-59 years. Part 1 Single Ascending Dose (SAD) will enroll 48 participants into six cohorts (S1-S6) to receive single oral doses of VNT-101 (100-1500 mg) or placebo under fasting or fed (S5 only) conditions. Part 2 Multiple Ascending Dose (MAD) will enroll 30 participants into three cohorts (M1-M3) to receive multiple oral doses of VNT-101 (250-750 mg BID Days 1-5, QD Day 6) or placebo under fasting conditions. Dose escalation in both parts will proceed after Protocol Safety Review Team (PSRT) review. The primary objective for Part 1 is to evaluate the safety and tolerability of single ascending oral (SAD) doses of VNT-101 in healthy adult participants under either fasting or fed conditions. The primary objective for part 2 is to evaluate the safety and tolerability of multiple ascending oral (MAD) doses of VNT-101 in healthy adult participants.
Phase 1
Recruiting
Altasciences Inc - Kansas City
Have you considered Advil Allergy Sinus clinical trials? We made a collection of clinical trials featuring Advil Allergy Sinus, we think they might fit your search criteria.Go to Trials
Image of University of the Fraser Valley in Chilliwack, Canada.

Mind-Body App + Movement Program for Chronic Pain

19 - 75
All Sexes
Chilliwack, Canada
The investigators are evaluating the effects of a mind-body mobile application, in combination with a guided movement program, on the experience of chronic pain. Participants meeting the criteria for chronic/persistent pain (confirmed via self-report) will complete an online baseline questionnaire. Eligible participants will take part in an intervention that involves use of a 6-week free trial of a mind-body focused mobile application in combination with virtual asynchronous audio-guided somatic education sessions (gentle movement). External data from a usual care control arm and a mobile-app-only arm from a previous study by the same research team, National Clinical Trials (NCT) registry number NCT05090683, will be used for comparison with the current combined intervention. All participants will complete online surveys at the start of the study and after 6 weeks to measure pain intensity and interference (primary outcomes), mental health outcomes (depression, anxiety, stress), pain-related thoughts (pain catastrophizing), quality of life, and fear of movement (secondary outcomes). From weeks 2 to 6, participants will fill out weekly surveys to track how often they engage with each: the somatic education (gentle movement) program and the mobile app. Participants will also complete a follow-up survey at 12 weeks (6 weeks post-intervention conclusion).
Waitlist Available
Has No Placebo
University of the Fraser ValleyCynthia J Thomson, PhD
Image of Miami Valley Hospital in Dayton, United States.

Intranasal Nerve Block for Headache

18+
All Sexes
Dayton, OH
In patients with bleeding from a brain aneurysm, severe headache is the most common complaint. However, the pain is difficult to treat. The use of standard pain medications is common, but pain control remains poor. Additionally, pain medicines have multiple side effects including sedation, interference with breathing, intestinal cramping, low blood pressure, and the risk of addiction. In the present study, the investigators will examine the use of a medication to block the sphenopalatine ganglion which is a bundle of nerves that includes nerves that cause head pain. This block is performed by spraying numbing medication into the back of the nasal cavity on both sides. This particular pain medication does not have the side effects discussed above. The purpose of the study is to see if this treatment will decrease pain without causing unwanted side effects. All patients in the study will receive standard pain medicine as needed for headache. Information will be collected from the patient's medical chart on the amount of pain medication used and the amount of pain the patient describes having. The average pain will be calculated for the first 24 hours the patient is in the hospital. At that point, the patient will receive pain medication sprayed into the back of the nasal cavity on both sides. Patients will also receive this treatment 3 days later. Following these treatments, information will be obtained on the average amount of pain, and how much other pain medication is used. The investigators will look at the amount of pain and the amount of other pain medicine used over the first 24 hours before the nasal pain medicine treatment and compare it to the time after the treatments to see if the amount of pain decreases and if the amount of other pain medicine needed decreases as well. Six months after discharge, the patient will be contacted by phone to find out more information about how much head pain they had after discharge from the hospital.
Phase 4
Recruiting
Miami Valley Hospital
Image of University of Maryland, School of Medicine, Center for Vaccine Development and Global Health in Baltimore, United States.

pH1N1 Virus for Flu

18 - 55
All Sexes
Baltimore, MD
This protocol describes a clinical trial to develop and validate a Controlled Human Infection Model (CHIM) for influenza A/Arkansas/08/2020 (pH1N1). The study is designed to determine the optimal infectious dose of the pH1N1 challenge strain for use in future clinical trials evaluating influenza countermeasures. The study will enroll and challenge adult volunteers with the pH1N1 influenza virus challenge or sham inoculations. Given the adaptive design of this trial, the potential number of participants can vary. Depending on the pathway recommended by the PSRT and followed in the Trial Schema, the study population can range from around 30 to 120. However, it is anticipated that the final sample size will be around 60 participants receiving pH1N1 challenge product plus approximately 4 persons receiving a sham inoculation. Participants will be pre-screened for health and for serological HAI antibody titers of \</1:40 against the challenge strain. Eligible participants will be enrolled sequentially into challenge cohorts and will be randomly assigned to receive a single dose of either sham inoculation or the interventional study product at a dose between 10\^6 to 10\^7 TCID50 (or 10\^5 TCID50 if needed). Dose titration will be conducted under an adaptive escalation schedule whereby dosing will start at 10\^6 TCID50 and escalate to the next dose if a pre-determined symptomatic influenza attack rate and clinical symptom score thresholds are not met and if the dose is determined to be safe with no pre-defined halting criteria being met. The primary objectives of this study are to determine the optimal infectious dose of a pH1N1 viral challenge to cause laboratory-confirmed clinical influenza and to assess the safety profile of pH1N1 viral challenge.
Phase 1
Recruiting
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health (+1 Sites)
Have you considered Advil Allergy Sinus clinical trials? We made a collection of clinical trials featuring Advil Allergy Sinus, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security